Charge what you will ... reimbursements are shrinking.

作者信息

Crane M

出版信息

Med Econ. 1998 Sep 21;75(18):128-30, 133, 137-8 passim.

PMID:10185526

Abstract

摘要

相似文献

Charge what you will ... reimbursements are shrinking.

Med Econ. 1998 Sep 21;75(18):128-30, 133, 137-8 passim.

Reimbursements. Inching closer to actual charges.报销。正逐渐接近实际费用。

Med Econ. 2000 Nov 20;77(22):32-4, 37-40, 45-8, 50.

Fee survey. Charges vs reimbursements: the gap widens again.

Med Econ. 1999 Oct 11;76(19):180-2, 185-90, 192.

Getting peanuts.

Med Econ. 1997 Sep 22;74(19):144-6, 149-52, 154-60.

What you charge vs. what you're paid.你的收费与所得报酬之比。

Med Econ. 1995 Oct 9;72(19):156-8, 163, 167-8 passim.

Exclusive survey. Fees & reimbursements.独家调查。费用与报销。

Med Econ. 2003 Oct 10;80(19):96-8, 104-6, 109.

Third parties keep on chopping fees.

Med Econ. 1996 Sep 23;73(18):176-7, 181-2, 185-6 passim.

Bridging the reimbursement gap.弥合报销差距。

Med Econ. 2002 Nov 8;79(21):96-8, 103-4, 107.

Do you know how much to charge?你知道要收多少钱吗？

Med Econ. 1993 Oct 11;70(19):106-12, 117, 121-33.

What you charge vs what you get.

Med Econ. 2001 Oct 22;78(20):50-2, 55-7.

引用本文的文献

Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.沙美特罗/丙酸氟替卡松与孟鲁司特治疗成人持续性哮喘的成本效益比较

Pharmacoeconomics. 2002;20(13):909-18. doi: 10.2165/00019053-200220130-00004.

Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma.丙酸氟替卡松与扎鲁司特治疗持续性哮喘患者的成本-效果分析

Pharmacoeconomics. 2001;19(8):865-74. doi: 10.2165/00019053-200119080-00008.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验